医药行业分析
- (2021-06-11)
- (2021-06-11)
- (2021-06-11)
- (2021-06-11)
- (2021-06-11)
- (2021-06-11)
- (2021-06-11)
- (2021-06-11)
- (2021-06-11)
- (2021-06-11)
- (2021-06-11)
- (2021-06-10)
- (2021-06-10)
- (2021-06-10)
- (2021-06-10)
- (2021-06-10)
- (2021-06-10)
- (2021-06-10)
- (2021-06-10)
- (2021-06-10)
百济神州和Shoreline Biosciences宣布在基因修饰的自然杀伤(NK)细胞疗法领域开展全球研发和商业化战略合作
(2021-06-10)- (2021-06-10)
- (2021-06-10)
- (2021-06-10)
- (2021-06-10)
- (2021-06-10)
- (2021-06-10)
- (2021-06-10)
- (2021-06-10)
- (2021-06-09)
- (2021-06-09)
- (2021-06-09)
- (2021-06-09)
- (2021-06-09)
- (2021-06-09)
- (2021-06-09)
- (2021-06-09)
- (2021-06-09)
- (2021-06-09)
- (2021-06-09)
- (2021-06-09)
- (2021-06-09)
- (2021-06-09)
- (2021-06-09)
- (2021-06-09)
- (2021-06-09)
- (2021-06-08)
- (2021-06-08)
- (2021-06-08)
- (2021-06-08)
- (2021-06-08)
- (2021-06-08)
- (2021-06-08)
- (2021-06-08)
- (2021-06-08)
- (2021-06-08)
- (2021-06-08)
- (2021-06-08)
- (2021-06-08)
- (2021-06-08)